Fekry Baharan, Jeffries Kristen A, Esmaeilniakooshkghazi Amin, Ogretmen Besim, Krupenko Sergey A, Krupenko Natalia I
From the Nutrition Research Institute, University of North Carolina at Chapel Hill, Kannapolis, North Carolina 28081.
the Department of Biochemistry and Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina 29425, and.
J Biol Chem. 2016 Aug 5;291(32):16586-96. doi: 10.1074/jbc.M116.716902. Epub 2016 Jun 14.
Our previous study suggested that ceramide synthase 6 (CerS6), an enzyme in sphingolipid biosynthesis, is regulated by p53: CerS6 was elevated in several cell lines in response to transient expression of p53 or in response to folate stress, which is known to activate p53. It was not clear, however, whether CerS6 gene is a direct transcriptional target of p53 or whether this was an indirect effect through additional regulatory factors. In the present study, we have shown that the CerS6 promoter is activated by p53 in luciferase assays, whereas transcriptionally inactive R175H p53 mutant failed to induce the luciferase expression from this promoter. In vitro immunoprecipitation assays and gel shift analyses have further demonstrated that purified p53 binds within the CerS6 promoter sequence spanning 91 bp upstream and 60 bp downstream of the transcription start site. The Promo 3.0.2 online tool for the prediction of transcription factor binding sites indicated the presence of numerous putative non-canonical p53 binding motifs in the CerS6 promoter. Luciferase assays and gel shift analysis have identified a single motif upstream of the transcription start as a key p53 response element. Treatment of cells with Nutlin-3 or low concentrations of actinomycin D resulted in a strong elevation of CerS6 mRNA and protein, thus demonstrating that CerS6 is a component of the non-genotoxic p53-dependent cellular stress response. This study has shown that by direct transcriptional activation of CerS6, p53 can regulate specific ceramide biosynthesis, which contributes to the pro-apoptotic cellular response.
我们之前的研究表明,神经酰胺合酶6(CerS6)作为鞘脂生物合成中的一种酶,受p53调控:在几种细胞系中,p53的瞬时表达或叶酸应激(已知可激活p53)会使CerS6水平升高。然而,尚不清楚CerS6基因是否是p53的直接转录靶点,或者这是否是通过其他调控因子产生的间接效应。在本研究中,我们发现在荧光素酶检测中,CerS6启动子被p53激活,而转录无活性的R175H p53突变体未能诱导该启动子的荧光素酶表达。体外免疫沉淀试验和凝胶迁移分析进一步证明,纯化的p53结合在CerS6启动子序列内,该序列跨越转录起始位点上游91 bp和下游60 bp。用于预测转录因子结合位点的在线工具Promo 3.0.2表明,CerS6启动子中存在许多假定的非经典p53结合基序。荧光素酶检测和凝胶迁移分析已确定转录起始位点上游的一个单一基序是关键的p53反应元件。用Nutlin-3或低浓度放线菌素D处理细胞会导致CerS6 mRNA和蛋白质水平显著升高,从而证明CerS6是非基因毒性p53依赖性细胞应激反应的一个组成部分。这项研究表明,p53可通过直接转录激活CerS6来调节特定的神经酰胺生物合成,这有助于细胞的促凋亡反应